These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Trisomy 21 as the sole acquired karyotypic abnormality in an adult patient with CD7-positive acute myeloid leukemia. Kondo H; Kobayashi A; Iwasaki H Cancer Genet Cytogenet; 2001 May; 127(1):77-9. PubMed ID: 11408071 [TBL] [Abstract][Full Text] [Related]
4. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement. Nagata T; Higashigawa M; Nagai M; Zhang XL; Azuma E; Komada Y; Sakurai M Leuk Res; 1996; 20(11-12):983-5. PubMed ID: 9009257 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0. Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387 [TBL] [Abstract][Full Text] [Related]
6. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F; Chen Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [TBL] [Abstract][Full Text] [Related]
7. Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia. El-Sissy AH; El-Mashari MA; Bassuni WY; El-Swaayed AF J Egypt Natl Canc Inst; 2006 Sep; 18(3):244-9. PubMed ID: 17671534 [TBL] [Abstract][Full Text] [Related]
8. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome. Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia]. Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262 [TBL] [Abstract][Full Text] [Related]
10. Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn. Svaldi M; Moroder W; Messner H; Battisti L; Venturi R; Coser P; Mitterer M J Pediatr Hematol Oncol; 2002; 24(5):394-6. PubMed ID: 12142790 [TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation. Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253 [TBL] [Abstract][Full Text] [Related]
12. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia]. Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362 [TBL] [Abstract][Full Text] [Related]
13. Neural cell-adhesion molecule (CD 56)-positive, t(8;21) acute myeloid leukemia (AML, M-2) and granulocytic sarcoma. Krishnan K; Ross CW; Adams PT; Pereira A; Roth MS Ann Hematol; 1994 Dec; 69(6):321-3. PubMed ID: 7527661 [TBL] [Abstract][Full Text] [Related]
14. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection]. Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311 [TBL] [Abstract][Full Text] [Related]
15. Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule. Byrd JC; Weiss RB Cancer; 1994 Apr; 73(8):2107-12. PubMed ID: 7512442 [TBL] [Abstract][Full Text] [Related]
16. [Cerebral and testicular myeloblastoma formation in relapsing acute myeloid leukemia (M1) with t(8;21)]. Kobayashi T; Horikoshi A; Endo M; Ashiya M; Iizuka Y; Takeuchi J; Ohshima T; Horie T Rinsho Ketsueki; 1993 Mar; 34(3):321-7. PubMed ID: 7683065 [TBL] [Abstract][Full Text] [Related]
17. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0. Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912 [TBL] [Abstract][Full Text] [Related]
18. FLT3-internal tandem duplication in a pediatric patient with t(8;21) acute myeloid leukemia. Kawamura M; Kaku H; Ito T; Funata N; Taki T; Shimada A; Hayashi Y Cancer Genet Cytogenet; 2010 Dec; 203(2):292-6. PubMed ID: 21156247 [TBL] [Abstract][Full Text] [Related]
19. The importance of CD7 and CD56 antigens in acute leukaemias. Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863 [TBL] [Abstract][Full Text] [Related]
20. Trisomy 10 in acute myeloid leukemia. Three additional cases from the database of the Japan Adult Leukemia Study Group (JALSG) AML-92 and AML-95. Suzuki A; Kimura Y; Ohyashiki K; Kitano K; Kageyama S; Kasai M; Miyawaki S; Ohno R Cancer Genet Cytogenet; 2000 Jul; 120(2):141-3. PubMed ID: 10942805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]